← Back to front page
Oceania · News · The Mercury

Optiscan’s digital pathology tech hits major US FDA milestone

Published by The Mercury · Australia 15 h ago

Optiscan Imaging has hit a major US regulatory milestone, lodging its FDA 510(k) submission for InForm and moving the digital pathology device into formal review.

Read the full article on The Mercury Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.themercury.com.au)

Also worth reading

The Age

Revealed: Hawks’ opening offer for Merrett as trade war resumes

 Brisbane Times

Revealed: Hawks’ opening offer for Merrett as trade war resumes

 WAtoday

Revealed: Hawks’ opening offer for Merrett as trade war resumes

 PerthNow

‘Left with no choice’: Jetstar workers to strike at major airports ahead of Grand Final weekend

 The Conversation AU

View from The Hill: how far will the opposition go on industrial relations reform? Probably not too far

 The Guardian Australia

First home buyers with big loans among those most at risk of falling into negative equity, RBA warns